trimetazidine has been researched along with Hypertrophy, Left Ventricular in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Jin, C; Li, Y; Luan, Y; Wang, M; Wu, L; Zhang, W | 1 |
| Beker, DL; Fillmore, N; Jaswal, JS; Keung, W; Lopaschuk, GD; Mori, J; Ussher, JR; Wagg, CS | 1 |
| Chen, A; Chen, M; Chen, X; Dai, W; Dong, Q; Li, W; Li, X; Ou, C; Shen, Y | 1 |
| Chirkov, YY; Horowitz, JD; Kennedy, JA; Sverdlov, AL | 1 |
| Barkhudarian, AL; Sisakian, AS; Torgomian, AL | 1 |
1 review(s) available for trimetazidine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Modulation of myocardial metabolism: an emerging therapeutic principle.
Topics: Acetanilides; Amiodarone; Cardiovascular Agents; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Reperfusion; Myocardium; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2010 |
2 trial(s) available for trimetazidine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Cardiovascular Agents; China; Coronary Artery Disease; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Recovery of Function; Time Factors; Treatment Outcome; Trimetazidine; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2020 |
[The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
Topics: Aged; Cardiomyopathies; Exercise; Exercise Tolerance; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Ischemia; Trimetazidine; Vasodilator Agents | 2006 |
2 other study(ies) available for trimetazidine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Trimetazidine therapy prevents obesity-induced cardiomyopathy in mice.
Topics: Acetyl-CoA C-Acyltransferase; Animals; Cardiomyopathies; Echocardiography; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Obesity; Oxidation-Reduction; Palmitates; Trimetazidine; Vasodilator Agents | 2014 |
Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Aorta, Abdominal; Arterial Pressure; Cardiovascular Agents; Constriction; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Myocardium; Neuropeptide Y; Oxidative Stress; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Receptors, Neuropeptide Y; Signal Transduction; Trimetazidine; Ventricular Function, Left; Ventricular Remodeling | 2016 |